europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Library
Become a member
✕

The Lithuanian Biotechnology Association joins EuropaBio: it’s time to put Lithuania on a map of the most biotech savvy nations

28/04/2021
PRESS RELEASE

The Lithuanian Biotechnology Association joins EuropaBio: it’s time to put Lithuania on a map of the most biotech savvy nations

Brussels, 28 April 2021 – EuropaBio is pleased to announce that the Lithuanian Biotechnology Association (LBTA) has joined the National Association Council (NAC).

The LBTA has 29 industry and academic members and has a focus on life sciences, health technologies and bioeconomics. It has the mission to build on an existing established economic foundation from biotechnology, with national activities including vaccine manufacture. As part of the EuropaBio NAC, LBTA will feature in the May 10 NAC Summit ‘Building on biotechnology: From vaccines to economic growth for Europe’, discussing how Europe must build from the advances in policy, funding and collaboration during Covid, to enable continued economic growth from biotech.

EuropaBio Director-General Dr. Claire Skentelbery says “LBTA really demonstrates how all European countries play a critical role in delivering biotechnology as an economic and societal contributor. We are delighted to bring their expertise into the National Associations Council and look forward to the NAC Summit on May 10”.

Agne Vaitkeviciene, Executive Director of the LBTA added ”Lithuania is pioneering in genome editing technologies [CRIPSR-CAs9] that has immense potential in the DNA/RNA vaccine development. In addition, we have immense scientific expertise in the field related to emerging non-viral vaccine technology. Faster recovery from pandemics calls for collaboration and Lithuania is ready to share its biotech potential and to contribute to production and development of life-saving biotech products.

Download the full PRESS RELEASE below.

Website Size (1)

The Lithuanian Biotechnology Association joins EuropaBio


Download
LBTA-final_Press-ReleaseDownload

Share
Alexandra Simionca
Alexandra Simionca

Related posts

17/01/2023

EuropaBio launches SME BioForum in Rare Diseases


Read more
17/01/2023

EuropaBio launches Industry Advisory Group for new Biomanufacturing Platform


Read more
16/01/2023

SwiftPharma joins EuropaBio: pioneering sustainable, scalable and affordable plant-made therapeutic proteins


Read more
19/12/2022

EuropaBio sat down with new member Association of Biotechnological Companies Bioforum, to find out how they champion biotech in central and eastern Europe


Read more

Important links

  • EuropaBio launches SME BioForum in Rare Diseases
  • EuropaBio launches Industry Advisory Group for new Biomanufacturing Platform

Categories in our Newsroom

Search by tags

  • Innovation
  • Excellence
  • Science
  • ATMPs
  • Healthcare Biotech
  • Industrial Biotech
  • Investment
  • EuropaBio
  • EFIB
  • Regulation
  • Rare Diseases
  • COVID-19
  • Members
  • Cancer
  • Patients
  • Patient BioForum
  • Gene & Cell Therapies
  • Accessibility
  • Intellectual Property
  • Pharmaceutical Strategy for Europe

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member